Watch the video of a special moment: our debut on the Italian Stock Exchange!
The first new listing of 2020 on the MTA, the main market of Borsa Italiana
The first new listing of 2020 on the MTA, the main market of Borsa Italiana
GVS announced that it has entered into a binding agreement with Ningbo Fuji Medical Technology Co., Ltd., a company controlled by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., to acquire the entire share capital of Shanghai Transfusion Technology Co., Ltd., a Shanghai headquartered company active in the production and sale of blood management related products. The
GVS has acquired the 100% of the share capital of the Italian Group Haemotronic, a leading supplier of advanced filtration solutions for highly critical applications and a specialized producer of components and bags for the medical sector with plants in Italy and Mexico. In line with its strategy, the acquisition of the company contributes to
GVS Malaysia experts are always here for you! Contact us now if you have any questions!
You are currently at GVS Malaysia website. To visit the global website, click the button below.
You are currently at GVS Malaysia website. To visit the global website, click the button below.